BFC Planning’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
BFC Planning's NVCR Position: Q3 2026 in Review
BFC Planning held its NovoCure (NVCR) position steady in Q3 2026 at 519 shares worth $8.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.
BFC Planning first reported a position in NVCR in Q3 2024 and has held it in 9 quarters since. The position peaked at $15.5K in Q4 2024. 185 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- BFC Planning held 519 shares of NovoCure worth $8.28K as of Q3 2026.
- BFC Planning left its NovoCure share count unchanged in Q3 2026.
- NovoCure made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2477 holding.
- BFC Planning first reported a position in NovoCure in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's NovoCure position peaked at $15.5K in Q4 2024.
- 185 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.